Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioidbased treatments

Details for Australian Patent Application No. 2004246817 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Meert, Theo Frans; Janssens, Frans Eduard; Sommen, Francois Maria; Leenaerts, Joseph Elisabeth; De Boeck, Benoit Christian Albert Ghislain; Van Roosbroeck, Yves Emiel Maria

Agent Shelston IP

Pub. Number AU-A-2004246817

PCT Pub. Number WO2004/110415

Priority PCT/EP03/50220 10.06.03 EP

Filing date 7 June 2004

Wipo publication date 23 December 2004

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/110415 Priority application(s): WO2004/110415

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004246819-Formoterol and ciclesonide combination

2004246812-Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen